haylaavo

J B CHEMICALS AND PHARMA

JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
Series
EQ
F&O
No
Status
Inactive since 17 Jul 2026

Source: NSE equity master · as of 16 Jul 2026

Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —

Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 01:44 IST
  • 30 Nov 2022 14:17
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about ANDA approval received for Venlafaxine Hydrochloride Extended-Release Tablets from USFDA.

    PDF · -
  • 18 Nov 2022 14:28
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call

    PDF · -
  • 17 Nov 2022 19:52
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme

    PDF · -
  • 16 Nov 2022 19:33
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about related party transaction for the period ended September 2022

    PDF · -
  • 14 Nov 2022 18:57
    Analyst meet

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Audio Recording of Investors/Analysts Call with Management

    PDF · -
  • 12 Nov 2022 18:05
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about newspaper cutting of extract of consolidated financial results for quarter ended on September 30, 2022

    PDF · -
  • 11 Nov 2022 18:36
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Issue of duplicate share certificate

    PDF · -
  • 11 Nov 2022 18:34
    Analyst meet

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 11 Nov 2022 18:33
    Business update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about press release dated 11-Nov-2022 titled Press Release

    PDF · -
  • 11 Nov 2022 18:30
    Board meeting

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about outcome of Board Meeting held on 11-Nov-2022 to consider financial statements for the period ended September 2022

    PDF · -
  • 05 Nov 2022 14:33
    Analyst meet

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call

    PDF · -
  • 13 Oct 2022 16:01
    Business update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about press release dated 13-Oct-2022 titled Press release

    PDF · -
  • 13 Oct 2022 15:53
    Other

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Sustainability Report for the financial year 2021-22

    PDF · -
  • 11 Oct 2022 17:11
    General update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

    PDF · -
  • 30 Sept 2022 14:16
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Closure of trading window

    PDF · -
  • 28 Sept 2022 11:30
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of share certificate

    PDF · -
  • 27 Sept 2022 12:32
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of share certificate

    PDF · -
  • 13 Sept 2022 16:09
    Insider / SAST

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme.

    PDF · -
  • 08 Sept 2022 13:22
    General update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript of 46th Annual General Meeting

    PDF · -
  • 25 Aug 2022 16:34
    Other

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 24-Aug-2022

    PDF · -
  • 24 Aug 2022 18:47
    Other

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Proceedings of Annual General Meeting held on 24-Aug-2022

    PDF · -
  • 20 Aug 2022 20:43
    Insider / SAST

    J.B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme

    PDF · -
  • 09 Aug 2022 15:20
    Analyst meet

    J.B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript of Investors/Analysts Call

    PDF · -
  • 09 Aug 2022 15:09
    Compliance

    J.B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of share certificate

    PDF · -
  • 05 Aug 2022 17:17
    Analyst meet

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Audio Recording of Investors/Analysts Call

    PDF · -
  • 05 Aug 2022 16:20
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for the quarter ended on June 30, 2022

    PDF · -
  • 04 Aug 2022 20:02
    Other

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure of other UPSI/material event

    PDF · -
  • 04 Aug 2022 19:22
    Analyst meet

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · -
  • 04 Aug 2022 19:20
    Business update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about press release dated 04-Aug-2022 titled Press release.

    PDF · -
  • 04 Aug 2022 19:09
    Board meeting

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Board Meeting held on 04-Aug-2022 to consider financial statements for the period ended June 2022

    PDF · -
  • 29 Jul 2022 17:46
    Analyst meet

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call

    PDF · -
  • 29 Jul 2022 15:47
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper Advertisement.

    PDF · -
  • 29 Jul 2022 15:31
    Corporate action

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Aug-2022.

    PDF · -
  • 28 Jul 2022 17:11
    Other

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Notice of Annual General Meeting to be held on 24-Aug-2022

    PDF · -
  • 21 Jul 2022 18:27
    Other

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure of other UPSI/material event

    PDF · -
  • 12 Jul 2022 17:37
    General update

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

    PDF · -
  • 05 Jul 2022 15:00
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper Advertisement in respect of Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM).

    PDF · -
  • 30 Jun 2022 10:20
    Other

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure of other UPSI/material event

    PDF · -
  • 28 Jun 2022 15:27
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Closure of trading window

    PDF · -
  • 09 Jun 2022 18:42
    Compliance

    J.B. Chemicals & Pharmaceuticals Limited has informed the Exchange about related party transaction for the half year ended March 31, 2022

    PDF · -
  • 03 Jun 2022 14:18
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).

    PDF · -
  • 03 Jun 2022 13:55
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Loss of share certificate

    PDF · -
  • 01 Jun 2022 14:28
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Disclosure under regulation 30 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements) Regulations, 2015

    PDF · -
  • 31 May 2022 17:52
    Analyst meet

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript of Investors/Analysts Meet

    PDF · -
  • 28 May 2022 15:56
    Analyst meet

    J.B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Audio Recording of Investors/Analysts Meet

    PDF · -
  • 27 May 2022 14:40
    Compliance

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper cutting of extract of consolidated financial results for quarter and year ended on March 21, 2022

    PDF · -
  • 27 May 2022 11:22
    Analyst meet

    Investor Presentation on financial results for the quarter and year ended on March 31, 2022

    PDF · -
  • 26 May 2022 15:57
    Results

    JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

    PDF · -
  • 26 May 2022 15:50
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about press release dated 26-May-2022 titled Press Release

    PDF · -
  • 26 May 2022 15:40
    Dividend

    J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Recommendation of Final dividend at the rate of 8 per share

    PDF · -
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries